RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy.
Journal of the National Cancer Institute. Monographs（2015）
摘要
RDA is a novel intermediate endpoint that has promise for clinical utility for breast cancers early in response-guided primary systemic therapy.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要